Loading clinical trials...
Loading clinical trials...
To evaluate the rates of dyspareunia with rapidly absorbing polyglactin 910 compared to poliglecaprone 25 using a validated sexual function questionnaire. To assess maternal satisfaction with the lac...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Virginia Commonwealth University
NCT07504991 · Dyspareunia
NCT07257029 · Provoked Vestibulodynia, Secondary Provoked Vestibulodynia, and more
NCT05417334 · Dyspareunia
NCT06710002 · Menopause, Genitourinary Syndrome of Menopause, and more
NCT06840314 · Genito-Pelvic Pain/Penetration Disorder, Dyspareunia, and more
Virginia Commonwealth University
Richmond, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions